Clinical Efficacy and Safety of Alirocumab After ACS According to Achieved Level of LDL-C
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial
Circulation 2021 Jan 13;[EPub Ahead of Print], GG Schwartz, PG Steg, DL Bhatt, VA Bittner, R Diaz, SG Goodman, JW Jukema, YU Kim, QH Li, G Manvelian, R Pordy, T Sourdille, HD White, M Szarek,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.